Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

27.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.4K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Adult Stem Cells01:33

Adult Stem Cells

33.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
Induced-fit Model01:13

Induced-fit Model

88.9K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
88.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma.

Blood cancer discovery·2026
Same author

Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

Nature·2026
Same author

Somatic cancer variants enriched in Alzheimer's disease microglia-like cells drive inflammatory and proliferative states.

Cell·2026
Same author

Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes.

Experimental hematology·2026
Same author

Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcoma.

bioRxiv : the preprint server for biology·2026
Same author

Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.

Cancer discovery·2025

Related Experiment Video

Updated: Jan 20, 2026

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
10:24

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

22.0K

Modeling Leukemia with Human Induced Pluripotent Stem Cells.

Eirini P Papapetrou1,2,3,4

  • 1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA eirini.papapetrou@mssm.edu.

Cold Spring Harbor Perspectives in Medicine
|August 28, 2019
PubMed
Summary
This summary is machine-generated.

Induced pluripotent stem cells (iPSCs) offer powerful models for studying hematologic malignancies. This review explores their practical applications, recent advancements, and future potential in disease research and therapy.

More Related Videos

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.7K
Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix
10:48

Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix

Published on: July 7, 2017

9.2K

Related Experiment Videos

Last Updated: Jan 20, 2026

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
10:24

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

22.0K
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
12:40

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

10.7K
Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix
10:48

Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix

Published on: July 7, 2017

9.2K

Area of Science:

  • Stem cell biology
  • Hematology
  • Cancer research

Background:

  • Induced pluripotent stem cells (iPSCs) have revolutionized disease modeling.
  • iPSC technology enables the creation of patient-specific cell lines.
  • Hematologic malignancies are a significant area for iPSC applications.

Purpose of the Study:

  • To discuss practical aspects of using iPSCs for modeling malignant hematologic diseases.
  • To review recent studies employing iPSC models in this field.
  • To explore the opportunities, limitations, and future prospects of iPSC technology in hematologic oncology.

Main Methods:

  • Review of existing literature on iPSC models for hematologic malignancies.
  • Discussion of practical considerations for generating and utilizing these models.
  • Analysis of current research trends and challenges.

Main Results:

  • iPSC models have been successfully generated for various hematologic diseases, including leukemias and lymphomas.
  • These models allow for the study of disease mechanisms in patient-derived cells.
  • Recent studies highlight the potential of iPSCs for drug screening and personalized medicine.

Conclusions:

  • iPSC technology provides a valuable platform for understanding and potentially treating hematologic malignancies.
  • Further development is needed to overcome current limitations and fully realize the therapeutic potential.
  • iPSC-based research holds significant promise for advancing hematologic oncology.